Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy

Abstract Aims Peripartum cardiomyopathy (PPCM) is a pregnancy‐associated cardiomyopathy that occurs in previously heart‐healthy women towards the end of pregnancy or in the first months after delivery and is characterized by heart failure due to systolic dysfunction. The clinical course of PPCM diff...

Full description

Bibliographic Details
Main Authors: Tobias J. Pfeffer, Manuel List, Julia H. Müller, Michaela Scherr, Johann Bauersachs, Denise Hilfiker‐Kleiner, Melanie Ricke‐Hoch
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Peripartum cardiomyopathy (PPCM)
Cardiogenic shock
Perhexiline
B‐adrenergic receptor stimulation
ErbB4
Online Access:https://doi.org/10.1002/ehf2.13412

Internet

https://doi.org/10.1002/ehf2.13412

Similar Items